study sample analysis [Bioanalytics]

posted by Falisa_Mustafa – Malaysia, 2012-01-20 05:06 (5257 d 20:24 ago) – Posting: # 7969
Views: 3,577

hi,

i would like to seek some advice regarding the analysis of study sample from regulatory point of view.

scientifically, would it be acceptable to not analyze all study samples from a in a single run (i.e multiple runs) as long as the bioanalytical method has completely been validated and documented acceptable inter-assay variability?.
is there any justification behind the acceptance of single / multiple run(s) analysis results?

is there any references/guidelines that i can refer to regarding this matter?

thanx!

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
145 visitors (0 registered, 145 guests [including 30 identified bots]).
Forum time: 02:30 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5